Palo Alto, CANCT06797245Now EnrollingIRB Ready

Overactive Bladder (OAB) Clinical Trial in Palo Alto, CA

Access cutting-edge overactive bladder (oab) treatment through this clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.

Sponsored by Medstar Health Research Institute

Quick Self-Assessment

See if you qualify for this Palo Alto location

Preparing your pre-screening questions…

Expert Care in Palo Alto

Access overactive bladder (oab) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related overactive bladder (oab) treatment provided free

Apply for This Palo Alto Location

Check if you qualify for this overactive bladder (oab) clinical trial in Palo Alto, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Palo Alto

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Palo Alto site if eligible
  4. 4Begin participation

About This Overactive Bladder (OAB) Study in Palo Alto

The APPROVE trial is a multi-centered, randomized controlled trial designed to assess differences in symptom improvement, quality of life, bladder symptoms, satisfaction with treatment and continued treatment efficacy in women with overactive bladder (OAB) randomized to a prescription digital therapeutic (PDTx) app called RiSolve compared to standard behavioral education (handouts).

Sponsor: Medstar Health Research Institute

Who Can Participate

Inclusion Criteria

Women ≥ 22 years old
Bothersome OAB symptoms (defined as bother rating ≥ 5 on ICIQ-FLUTS question #3b or #9b)
English-speaking
Willing to forego other treatment outside of medications for the 8-week trial period
Use of at least one mobile App

Exclusion Criteria

Stress-predominant mixed urinary incontinence (defined as QUID stress score \> QUID urge score)
Voiding dysfunction defined as response ≥ 2 on ICIQ-FLUTS question #7a
Bladder pain defined as response ≥ 2 on ICIQ-FLUTS question #4a
Use of an OAB medication (anticholinergic or beta-agonist) within the past two weeks
Currently using intermittent or indwelling catheter
History of bladder/urethral, colon/anal, or cervical cancer
Current or prior use of sacral neuromodulation, tibial stimulation or onabotulinum toxin type A intradetrusor injection
Currently taking antibiotics/drugs for urinary tract infection\^
Currently undergoing or unwilling to forego pelvic floor physical therapy with a physical therapist or prescription device for the 8-week intervention period
Planning surgery for pelvic organ prolapse within 12 months of randomization
Pelvic surgery within the past 6 months
Planning to undergo pessary fitting °
Those on antibiotics for urinary tract infection will be eligible for enrollment 2 weeks after completing antibiotic therapy with subjective resolution of UTI symptoms °Will be eligible after completing pessary fitting https://researchdata.medstar.net/redcap/surveys/?s=MM7WN7EXACX4PNXJ

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Palo Alto?

Yes, this clinical trial (NCT06797245) has an active research site in Palo Alto, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Overactive Bladder (OAB) Treatment Options in Palo Alto, CA

If you're searching for overactive bladder (oab) treatment options in Palo Alto, CA, this clinical trial (NCT06797245) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Palo Alto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced overactive bladder (oab) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all overactive bladder (oab) clinical trials near you to find additional studies recruiting in your area.

More Alzheimers Disease Trials in Palo Alto, CA

See all alzheimers disease clinical trials recruiting in Palo Alto — not just this study.

Browse Alzheimers Disease Trials in Palo Alto →

Browse More Trials by Condition

Alzheimers Disease TrialsADHD TrialsRheumatoid Arthritis TrialsAtopic Dermatitis TrialsOveractive Bladder TrialsOsteoarthritis TrialsAll Conditions →

Ready to Join in Palo Alto?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Palo Alto, CA